Track the 诺诚健华 stock price and the full management transaction log of the company, a publicly traded company based in China. Shares trade on the CN market, under the authority of SSE / SZSE (CSRC). The latest transaction was disclosed on 17 July 2026 (Sale). Among the most active insiders: Jisong Cui(崔霁松). Every trade is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
5 of 5 declarations
Nuo Cheng Jian Hua is a company focused on the development of innovative drugs, concentrating on research and development of treatments for cancer and other serious diseases.